Hesperos Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 8

Hesperos General Information

Description

Developer of human-on-a-chip systems designed to accelerate drug discovery. The company's technology utilizes interconnected multi-organ in vitro platforms and serum-free media, enabling pharmaceutical and cosmetic firms to determine the efficacy and toxicity of novel therapeutics without animal testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12501 Research Parkway
  • Suite 100
  • Orlando, FL 32826
  • United States
+1 (407)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 12501 Research Parkway
  • Suite 100
  • Orlando, FL 32826
  • United States
+1 (407)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hesperos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. IPO 13-Jul-2022 Cancelled Generating Revenue
8. Later Stage VC 28-Sep-2023 Completed Generating Revenue
7. Debt - PPP 11-Apr-2020 Completed Generating Revenue
6. Grant 26-Sep-2019 Completed Generating Revenue
5. Grant 06-Sep-2018 Completed Generating Revenue
4. Grant 09-Nov-2016 Completed Generating Revenue
3. Grant 02-Apr-2016 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 23-Nov-2015 $690K Completed Generating Revenue
To view Hesperos’s complete valuation and funding history, request access »

Hesperos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of human-on-a-chip systems designed to accelerate drug discovery. The company's technology utilizes interconne
Biotechnology
Orlando, FL
45 As of 2023

New Orleans, LA
 

Beverly, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hesperos Competitors (31)

One of Hesperos’s 31 competitors is 28bio, a Venture Capital-Backed company based in New Orleans, LA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
28bio Venture Capital-Backed New Orleans, LA
Thrive Bioscience Venture Capital-Backed Beverly, MA
Emendo Biotherapeutics Formerly VC-backed Jersey City, NJ
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
InSphero Private Equity-Backed Schlieren, Switzerland
You’re viewing 5 of 31 competitors. Get the full list »

Hesperos Patents

Hesperos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026050698-A1 Method for prediction of drug-induced arrhythmogenicity during exercise-related cardiac stress Pending 29-Aug-2024
US-11697795-B2 Method and system for printing cells to a substrate comprising cell adhesive regions Active 07-Aug-2018
US-20200048602-A1 Method and system for printing cells to a substrate comprising cell adhesive regions Active 07-Aug-2018
CA-3048884-A1 Pumpless microfluidic organ-on-a-chip system including a functional immune system Active 30-Dec-2016
EP-3562591-A1 Pumpless microfluidic organ-on-a-chip system including a functional immune system Pending 30-Dec-2016 B01L3/502753
To view Hesperos’s complete patent history, request access »

Hesperos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hesperos Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Btomorrow Ventures Corporate Venture Capital Minority
National Center For Advancing Translational Sciences Government
National Institute of Environmental Health Sciences Government
National Institute on Aging Government
National Institute of Mental Health Government
You’re viewing 5 of 8 investors. Get the full list »

Hesperos FAQs

  • When was Hesperos founded?

    Hesperos was founded in 2015.

  • Where is Hesperos headquartered?

    Hesperos is headquartered in Orlando, FL.

  • What is the size of Hesperos?

    Hesperos has 45 total employees.

  • What industry is Hesperos in?

    Hesperos’s primary industry is Biotechnology.

  • Is Hesperos a private or public company?

    Hesperos is a Private company.

  • What is Hesperos’s current revenue?

    The current revenue for Hesperos is .

  • Who are Hesperos’s investors?

    Btomorrow Ventures, National Center For Advancing Translational Sciences, National Institute of Environmental Health Sciences, National Institute on Aging, and National Institute of Mental Health are 5 of 8 investors who have invested in Hesperos.

  • Who are Hesperos’s competitors?

    28bio, Thrive Bioscience, Emendo Biotherapeutics, Aspect Biosystems, and InSphero are some of the 31 competitors of Hesperos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process